The inextricable linkage of biomarkers and target discovery

Bound up in the progress of target discovery and validation is the role of biomarkers and the future of precision medicine. In the era of human first, target discovery and biomarkers have become inextricably linked. 

The application of multi-omics to patient data is yielding new targets that define subgroups of patients in new ways. The trend that began in oncology is expanding to other diseases, and will, eventually, force new ways of looking at diseases by pathway or mechanism rather than symptomology...